Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet — manufactured by Trumac Healthcare

Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg
Form: Tablet
Class: Antihistamine + Expectorant
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

T-Dryl 100 ml Syrup

T-Dryl 100 ml Syrup

Pack: 100ml (Case Size : 100 / 120 / 128 Pcs)

MRP: ₹80

View T-Dryl 100 ml Syrup →

Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Dry/productive cough
  • Night cough (sedating action)
  • Allergic cough
  • Post-nasal drip cough
Mechanism of Action

Diphenhydramine is first-generation H1 antihistamine with anticholinergic, sedative, and mild antitussive effects. Ammonium Chloride is expectorant — liquefies mucus.

Dosage & Administration
  • Adults: 5–10 ml every 4–6 hours.
  • Children: 5 ml every 6 hours.
Side Effects
  • Drowsiness (common), dry mouth, urinary retention.
Contraindications
  • Narrow-angle glaucoma, BPH with urinary retention, asthma (anticholinergic), infants <6 months.
Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise for Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 100ml (Case Size : 100 / 120 / 128 Pcs)
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet?

Trumac Healthcare is a WHO-GMP certified manufacturer of Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet available for PCD pharma franchise on monopoly basis?

Yes. We offer Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet?

Available pack sizes include: 100ml (Case Size : 100 / 120 / 128 Pcs).

What is the MRP / trade price for Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet?

MRPs range from ₹80 to ₹80 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Diphenhydramine HCl IP 14.08 mg + Ammonium Chloride IP 138 mg + Sodium Citrate IP 57.03 mg + Menthol IP 1.14 mg Tablet?

Get Pricing & Franchise Terms →